Course Code: REL-PAY-0-HHSDH
Hours: 0.5
Type: Online Course
Content Expiration Date: 12/31/2026
Learning Objectives:
Review what SDOH are and how they impact both healthcare access and quality of care.
Identify barriers to healthcare access and care quality, how these barriers negatively impact patient outcomes, and some strategic interventions to improve these patient outcomes.
Outline:
Section 1: Introduction
About This Course
Learning Objectives
Section 2: Overview
Meet Jade
SDOH
Healthcare Access and Quality
Revisiting Jade
Key Takeaways
Section 3: Barriers and Negative Outcomes
Overview
Provider Shortages
SDOH
Healthcare Inequities and Disparities
Health Literacy
Revisiting Jade
Key Takeaways
Section 4: Strategic Interventions
Healthy People 2030 Goals
Nurse and Provider Care Strategies
Revisiting Jade
Key Takeaways
Section 5: Conclusion
Course Summary
Course Contributor
References
Subject Matter Expert: Shalla Newton, MSN, RN, NE-BC
Shalla is a subject matter expert (SME)/writer for Relias. She completed her BSN and two undergraduate degrees with top honors from the University of Wisconsin-Madison. Shalla earned her dual MSN degrees from Johns Hopkins University with top honors. She also maintains her post-baccalaureate nurse educator certificate (NE-BC). Shalla’s tenure spans over 20 years of cross-functional leadership and direct clinical roles in healthcare, biopharma/biotech, government affairs, managed care/market access, nonprofit patient advocacy, and research. Her subject matter expertise is in rare, orphan, and complex diseases. Her sub-expertise is in immune-mediated diseases (rheumatology and immunology), genetics, neurology, hematology/oncology, several pediatric diseases, population/public health, and larger systemic healthcare affairs. Shalla is a published author with leading rare disease experts and a global speaker. She also sits on scientific, advocacy, and legislative advisory boards. She has led national advocacy and disease awareness campaigns, including speaking before congress, leading to the first-in-class rare disease biologic approval and investigative treatment protocols.
Target Audience:
The target audience for this course is: Nurses; Physicians; in the following settings: Acute Care Facility.
Relias Learning will be transparent in disclosing if any commercial support, sponsorship or co-providership is present prior to the learner completing the course.
Relias Learning has a grievance policy in place to facilitate reports of dissatisfaction. Relias Learning will make every effort to resolve each grievance in a mutually satisfactory manner. In order to report a complaint or grievance please contact Relias Learning at support@reliaslearning.com.
All courses offered by Relias Learning, LLC are developed from a foundation of diversity, inclusiveness, and a multicultural perspective. Knowledge, values and awareness related to cultural competency are infused throughout the course content.
To earn continuing education credit for this course you must achieve a passing score of 80% on the post-test and complete the course evaluation.
Course Delivery Method and Format
Asynchronous Distance Learning with interactivity which includes quizzes with questions/answers, and posttests.